Insmed Inc. (INSM) on Monday morning delivered information on its investigational lung antibiotic, called Arikace, that while optimistic, sent shares into an early nosedive. On a U.S. point, the ...
STAFFORD, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results